X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Kirske David sold 16,961 X4 Pharmaceuticals, Inc. shares (Form 4)
Traded May 12, 2026 · Filed May 13, 2026
On May 12, 2026, Kirske David (Chief Financial Officer) sold 16,961 X4 Pharmaceuticals, Inc. shares at US$4.29 for US$72,763, leaving 176,293 shares. Filed May 13, 2026 (Form 4).
- Sold
- 16,961 shares
- Price
- US$4.29
- Value
- US$72,763
- Holding after
- 176,293 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 12, 2026 | Common Stock | Sale | 16,961 | US$4.29 | 176,293 | Direct |
Source
Related
- X4 Pharmaceuticals, Inc.
- Kirske David
- X4 Pharmaceuticals, Inc. shareholders
- Form 4 · Kirske David · Oct 5, 2026
- Form 4 · Kirske David · Jul 1, 2026
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026